Jacobo Jacobo, Mauricio
Donnella, Hayley J.
Sobti, Sushil
Kaushik, Swati
Goga, Andrei
Bandyopadhyay, Sourav
Funding for this research was provided by:
Congressionally Directed Medical Research Programs (W81XWH-21-1-0774)
Mark Foundation Endeavor Award
Atwater Family Foundation
Division of Cancer Prevention, National Cancer Institute (U01CA168370)
National Institute of General Medical Sciences (R01GM107671)
Prospect Creek Foundation
Article History
Received: 11 October 2023
Accepted: 7 February 2024
First Online: 14 February 2024
Competing interests
: S.B. consults with and/or receives research funding from Pfizer, Ideaya Biosciences and Revolution Medicines and is an employee and shareholder in Rezo Therapeutics. No other authors have any conflict of interest on this work.